Jpmorgan Chase & Co »

Trisalus Life Sciences shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $115 25 4.60
2024-06-30 $110 20 5.50
2024-03-31 $103k 11k 9.75

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Trisalus Life Sciences

Wealthcare Advisory Partners
Duquesne Family Office
Vanguard Group
Geode Capital Management
Lido Advisors
MSDC Management
Exos Asset Management
Connecticut Wealth Management
BlackRock
BlackRock
Northern Trust
Vestcor Investment Management Corp
Goldman Sachs Group
Angelo, Gordon & Co
Virtu Financial

View all funds holding Trisalus Life Sciences